From: Identifying systematic reviews of the adverse effects of health care interventions
 | No of Papers Retrieved | No of Relevant Papers | Sensitivity (%) | Precision (%) |
---|---|---|---|---|
DARE (Quasi Gold Standard = 256) | Â | Â | Â | Â |
'floating' subheadings: 'adverse effects' OR 'drug effects' OR 'complications' OR 'poisoning' OR 'toxicity' OR 'chemically induced' | 1386 | 217 | 85% | 16% |
'floating' subheadings: 'adverse effects' OR 'drug effects' OR 'complications' OR 'poisoning', 'toxicity' OR 'chemically induced' OR Exp DRUG HYPERSENSITIVITY OR Exp DRUG TOXICITY OR Exp PRODUCT SURVEILLANCE, POSTMARKETING | 1386 | 217 | 85% | 16% |
synonyms of 'adverse effects' in the 'title' OR 'outcomes assessed in the review' field | 873 | 160 | 63% | 18% |
synonyms of 'adverse effects' in the title | 462 | 132 | 52% | 29% |
synonyms of 'adverse effects' in 'outcomes assessed in the review' field | 659 | 116 | 45% | 18% |
exp DRUG HYPERSENSITIVITY OR exp DRUG TOXICITY OR exp PRODUCT SURVEILLANCE, POSTMARKETING | 14 | 10 | 4% | 71% |
CDSR (Quasi Gold Standard = 14) | Â | Â | Â | Â |
'floating' subheadings: 'adverse effects' OR 'drug effects' OR 'complications' OR 'poisoning', 'toxicity' OR 'chemically induced' | 416 | 9 | 64% | 3% |
synonyms of 'adverse effects' near/20 objectives in the 'abstract' field | 1049 | 5 | 36% | 0.5% |
synonyms of 'adverse effects' in the 'title' field | 64 | 2 | 14% | 3% |
exp DRUG HYPERSENSITIVITY OR exp DRUG TOXICITY OR exp PRODUCT SURVEILLANCE, POSTMARKETING | 2 | 0 | 0% | 0% |